Cargando…

Detecting Infections Rapidly and Easily for Candidemia Trial (DIRECT1): A Prospective, Multicenter Study of the T2Candida Panel

BACKGROUND: Blood cultures (BC) are the diagnostic gold standard for candidemia, but sensitivity is <50%. T2 Candida (T2) is a novel, FDA-approved nanodiagnostic panel, which utilizes T2 magnetic resonance and a dedicated instrument to detect Candida within whole blood samples. METHODS: Candidemi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clancy, Cornelius J, Pappas, Peter, Vazquez, Jose, Judson, Marc A, Tobin, Ellis, Kontoyiannis, Dimitrios P, Thompson, George R, Reboli, Annette, Garey, Kevin W, Greenberg, Richard N, Ostrosky-Zeichner, Luis, Wu, Alan, Lyon, G Marshall, Apewokin, Senu, Nguyen, M Hong, Caliendo, Angela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632276/ http://dx.doi.org/10.1093/ofid/ofx162.122

Ejemplares similares

1166. Evaluating the Impact of the 2016 Candidemia Guidelines on the Incidence of Ocular Complications of Candidemia
por: Hillenbrand, Molly, et al.
Publicado: (2020)

Relationship of T2 Candida Panel to Disease Severity, Mortality and Time to Therapy in Patients with Candidemia
por: Turner, Orlando D, et al.
Publicado: (2017)

Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome
por: Reboli, Annette C, et al.
Publicado: (2011)

Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial
por: Vazquez, Jose, et al.
Publicado: (2014)

369. Using Hybrid Models and Blockchain Technology as a Means to Develop a Novel Propensity Score for Candidemia and Invasive Candidiasis
por: Rao, Arni Sr Srinivasa, et al.
Publicado: (2018)

1718. Rezafungin Clinical Safety and Efficacy in Patients With Candidemia and/or Invasive Candidiasis in the Randomized, Double-Blind, Multicenter, Phase 2 STRIVE Study
por: Thompson, George R, et al.
Publicado: (2018)

Candida glabrata candidemia
por: Chakrabarti, Arunaloke
Publicado: (2015)

Candida dubliniensis candidemia in Australia.
por: Marriott, D, et al.
Publicado: (2001)

Treatment of candidemia and invasive candidiasis in the intensive care unit: post hoc analysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin B
por: Dupont, Bertrand F, et al.
Publicado: (2009)

Intraleukocytic Candida is Diagnostic of Pathological Candidemia
por: Handoo, Anil, et al.
Publicado: (2012)

Candida auris Candidemia in Kuwait, 2014
por: Emara, Maha, et al.
Publicado: (2015)

Candida Blankii Candidemia an Emerging Threat
por: Ahmadkhani, Fardin, et al.
Publicado: (2023)

1173. Ocular Candidiasis in Patients with Candidemia Diagnosed by Blood Culture Versus T2Candida® Assay
por: White, Cameron, et al.
Publicado: (2020)

258. False Negative Rate of T2Candida Assay in Blood Culture Positive Candidemia
por: McCarty, Todd, et al.
Publicado: (2019)

Efficacy of T2 Magnetic Resonance Assay in Monitoring Candidemia after Initiation of Antifungal Therapy: the Serial Therapeutic and Antifungal Monitoring Protocol (STAMP) Trial
por: Mylonakis, Eleftherios, et al.
Publicado: (2018)

Rezafungin Versus Caspofungin in a Phase 2, Randomized, Double-blind Study for the Treatment of Candidemia and Invasive Candidiasis: The STRIVE Trial
por: Thompson, George R, et al.
Publicado: (2020)

Fatal Case of Candidemia due to Candida glabrata
por: Giri, Sidhartha, et al.
Publicado: (2014)

Candida auris–Associated Candidemia, South Africa
por: Magobo, Rindidzani E., et al.
Publicado: (2014)

Increase in Candida Parapsilosis Candidemia in Cancer Patients
por: Sun, Mingyue, et al.
Publicado: (2019)

810. Predictors of 30-Day Mortality Among Critically Ill Patients with Candidemia Identified by T2Candida Panel
por: Caniff, Kaylee E, et al.
Publicado: (2023)

4530 Elucidating the Influence of Chemotherapy (melphalan) and /or C. difficile toxin B Exposure on Beta-catenin Protein Expression in Caco-2 Monolayers
por: Canales, Jailene, et al.
Publicado: (2020)

248. Thirty-Day Mortality Among Patients with Candidemia Diagnosed by T2Candida Assay Alone: Influence of Risk Factors and Candida Species
por: White, Cameron, et al.
Publicado: (2019)

Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: Support for the 2009 IDSA treatment guidelines for candidiasis
por: Kett, Daniel H, et al.
Publicado: (2011)

Serological Profiling of a Candida albicans Protein Microarray Reveals Permanent Host-Pathogen Interplay and Stage-Specific Responses during Candidemia
por: Mochon, A. Brian, et al.
Publicado: (2010)

1134. Novel T2Candida Panel Assay Compared With Blood Cultures for Detection of Candidemia in Transplant and Non-Transplant Patients
por: Hussain, Noman, et al.
Publicado: (2018)

Correction: Serological Profiling of a Candida albicans Protein Microarray Reveals Permanent Host-Pathogen Interplay and Stage-Specific Responses during Candidemia
por: Mochon, A. Brian, et al.
Publicado: (2010)

The First Korean Case of Candidemia due to Candida dubliniensis
por: Yu, Nae, et al.
Publicado: (2012)

Candida score: a predictor of mortality in patients with candidemia
por: Juneja, D, et al.
Publicado: (2012)

Emergence of Non-Albicans Candida Species in Neonatal Candidemia
por: Juyal, Deepak, et al.
Publicado: (2013)

Sequence-identification of Candida species isolated from candidemia
por: Fathi, Naeimeh, et al.
Publicado: (2016)

A Fatal Case of Candida auris and Candida tropicalis Candidemia in Neutropenic Patient
por: Mohd Tap, Ratna, et al.
Publicado: (2018)

Induced Human Intestinal Organoids (iHIOs) as Model Systems for Chemotherapy-associated Clostridium difficile (CD) Infections
por: Apewokin, Senu, et al.
Publicado: (2017)

Recurrent episodes of Candidemia due to Candida glabrata, Candida tropicalis and Candida albicans with acquired echinocandin resistance
por: Grosset, Marine, et al.
Publicado: (2016)

Performance of the T2Candida Panel for the Diagnosis of Intra-abdominal Candidiasis
por: Lamoth, Frederic, et al.
Publicado: (2020)

Risk factors for fatal candidemia caused by Candida albicans and non-albicans Candida species
por: Cheng, Ming-Fang, et al.
Publicado: (2005)

The Role of Antifungals against Candida Biofilm in Catheter-Related Candidemia
por: Bouza, Emilio, et al.
Publicado: (2014)

Candida glabrata candidemia: An emerging threat in critically ill patients
por: Gupta, Ashish, et al.
Publicado: (2015)

The Utility of EQUAL Candida Score in Predicting Mortality in Patients with Candidemia
por: El Zakhem, Aline, et al.
Publicado: (2022)

Metagenomic analysis of the fecal microbiome in colorectal cancer patients compared to healthy controls as a function of age
por: Kharofa, Jordan, et al.
Publicado: (2022)

468. Assessment of The Proportion of Hospitalized Patients (Pts) with Candidemia (C) and Invasive Candidiasis without Candidemia (IC) Who Received an Echinocandin (EC) and Were Potentially Eligible for an Earlier Hospital Discharge (HD)
por: Lodise, Thomas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gauvsnr68c2co13vt8s6b964tu